Unlock instant, AI-driven research and patent intelligence for your innovation.

Behavioural treatment

A behavioral, individual technique for problem behaviors in infants and preschoolers that addresses unstudied gut-brain associations and more

Pending Publication Date: 2021-03-30
MURDOCH CHILDRENS RES INST
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] People with established disorders like autism and schizophrenia have altered gut microbiota, clinical study shows 6 ; however, gut-brain associations in normal human neurodevelopment remain unstudied

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Behavioural treatment
  • Behavioural treatment
  • Behavioural treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0162] Example 1 Association between infant gut microbiota during infancy and problem behavior at 2 years of age.

[0163] method

[0164]A. Sample and study design

[0165] The Barwon Infant Study (BIS) is a longitudinal Australian birth cohort study using an unselected prenatal sampling framework 16 (n=1074 infants) were pooled. Sociodemographic, family history, and maternal health data were collected from the first trimester, and stool samples were collected from 1-, 6-, and 12-month-old infants. The 16S rRNA gene was sequenced in a random subsample (n = 324), of which n = 201 had all relevant data available, and has been included in this study. Parents fill out the Child Behavior Scale when their child is 2 years old 17 (CBCL).

[0166] B. Microbiome

[0167] B.1 Collection and processing of stool samples

[0168] Fecal samples were collected from 1-, 6-, and 12-month-old BIS infants and stored at -80°C. In a random subsample of n=201 from BIS samples, 16S prepar...

Embodiment 2

[0220] Example 2 - Minimizing Anxiety Disorders in an Elevated Mouse Model

[0221] 1. Week 1 - Adaptation:

[0222] C57Bl / 6 wild-type mice were divided into 4 groups in the upper animal house, 4 mice per cage, and were not treated within a week, but closely monitored.

[0223] 2. Week 2 - Antibiotic therapy:

[0224] Administration of an antibiotic cocktail (1 g / L metronidazole, ampicillin, and neomycin) in drinking water for 7 days resulted in significant or complete elimination of bacteria (Bongers et al., 2014; Rakoff-Nahoum et al., 2004; Scher et al. , 2013).

[0225] 3. Week 3 - Bacterial inoculum preparation and P. Copri inoculation.

[0226] 4. Week 3-7 – P. Copri colonization

[0227] 5. Week 8 - Sucrose Preference Test

[0228]Animals had free access to 1% sucrose solution or normal water overnight. The bottles were weighed at the beginning and end of 17 hours. Since mice generally prefer sweet solutions over plain water, a diminished preference for sucrose ...

Embodiment 3

[0237] Example 3 Prevention of Internalizing Behavior at 2 Years Old

[0238] Take Prevotella or the gut bacterium Prevotella (P.copri) in infancy, preferably after the introduction of solid foods. When children were two years old, behavioral outcomes were assessed using the Children's Behavior Inventory. Once children reached school age, both parents and children assessed anxiety using the Spence Child Anxiety Inventory. Compare with placebo.

[0239] Without limitation, the invention can be summarized by the following

[0240] 1. A method of minimizing or reducing:

[0241] - the likelihood of problem behavior developing in the individual or

[0242] - the likelihood of individual problem behavior, or

[0243] - the development of problem behavior in the individual, or

[0244] - individual problem behavior,

[0245] The method includes administering to an individual a composition comprising a bacterium, wherein the composition comprises an effective amount of Prevo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to the treatment and prevention of problem behaviour by the administration of a composition that includes an effective amount of Prevotella.

Description

technical field [0001] The present invention relates to the assessment, treatment and prevention of problem behavior, including but not limited to problem behavior in infants and preschool children. [0002] Background of the invention [0003] Reference to any prior art in the specification is not an acknowledgment or implication that such prior art forms part of the common general knowledge in any jurisdiction, or that it could reasonably be expected to be understood, considered relevant and / or relevant to the art Combination of other prior art of the skilled person. [0004] Accumulating evidence indicates that the gut microbiome is critical for normal neurodevelopment through neuronal, hormonal and immune signaling 1 . Disruption of the gut microbiota is associated with abnormal hypothalamic-pituitary-adrenal axis stress responses, reduced expression of brain-derived neurotrophic factor, and impaired social behavior in germ-free mice, rodent studies show 2 . The influ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/74C12Q1/04A61P25/00
CPCA61K35/74A61P25/22A61P25/24C12Q1/689C12Q2600/118C12Q1/6883A61K2035/115A61K35/20A61K2300/00A61K35/741
Inventor P·维勒敏A-L·庞森白M·邓A·拉夫曼
Owner MURDOCH CHILDRENS RES INST